Document:

EXECUTIVE EMPLOYMENT AGREEMENT

 

EMPLOYMENT AGREEMENT,
dated this  24th day of January 2013 (the “Agreement”), by and among Organic Plant Health,
Inc., a Nevada corporation (the “Company”), and William Styles (the
“Executive”).

 

WHEREAS, the Company desires
to memorialize the engagement of the Executive who has been previously appointed to serve as the President and Spokesman
of the Organic Plant Health division of the Company and the Executive desires to continue to serve in such capacity pursuant
to the terms and conditions hereof;

 

NOW THEREFORE, in consideration
of the premises and the mutual agreements made herein, the Company and the Executive agree as follows:

 

1.Employment; Duties.

 

1.1Employment
by Company. The Company hereby engages the Executive to serve as President and Spokesman of the Organic Plant
Health division of the Company subject to the terms and conditions of this Agreement. The Executive shall serve the Company
in such capacity for the Employment Period as defined in Section 2 below. The Executive agrees that during the term of his employment
hereunder, he shall exclusively devote 100% of his professional working time, attention, knowledge and experience and give his
best effort, skill and abilities to promote the business and interests of the Company as reasonably directed by the Chief Executive
Officer (the “CEO”) pursuant to policies of the Board of Directors of the Company (the “Board”).
The Executive agrees to faithfully and diligently perform such duties as may from time to time be reasonably assigned by the CEO
under the terms and conditions of this Agreement.

 

1.2Services
as Spokesperson. The Executive shall serve as a spokesperson of the Company. In the discharge of the Executive’s duties
as spokesperson of the Company, the spokesperson shall be required from time to time to communicate with media and other individuals
regarding the Company’s current activities and future plans, and/or travel on behalf of the Company, in each case under the
direction of the CEO.

 

1.3Use of Image.
The Company and its licensees shall have the right to use the Executive’s photo, likeness and/or audio and visual recordings
of the Executive for purposes of advertising, marketing and otherwise promoting the Company and its products in advertisements
or similar communications of any kind, manner or medium, including but not limited appearances in advertisements in print, radio,
television or the internet, or on the packaging of products sold or licensed by the Company during the Term of this Agreement and
for Ten (10) years thereafter. The Executive shall cooperate with the Company in the production of such images and advertising,
and shall execute a release regarding the use of such images in the form of Exhibit A hereto.

 

2.Employment Period.
This Agreement shall have a term of three (3) years (the “Employment Period”) to be effective
as of the date hereof and ending on the third anniversary of the date of this Agreement. The period in which this Agreement shall
be effective within each Employment Period is referred to as a “Term”.

 

    	(1)

    	 

    
 

3.Compensation and
Benefits.

 

3.1Base Compensation and Annual
Bonus. The Executive shall be paid a base salary of One Hundred and Fifty Thousand Dollars ($150,000) per annum during
the Term, payable incrementally on a monthly basis and pro-rated for any partial year of employment, less applicable statutory
and regulatory deductions (each year, the “Base Salary”), which shall be payable in accordance with the Company’s
regular monthly payroll practices, as the same may be administered from time to time.

 

3.2 Cash Bonuses. The Executive
shall be entitled to receive a performance bonus of cash, less applicable statutory and regulatory deductions, in an amount equal
to the following: (i) to one and one half percent (1.5%) of the EBITDA of the Company attributable to revenues generated
from sale of the Organic Plant Health division’s products or services or licensing revenues derived from licensing the Organic
Plant Health division’s intellectual property and/or brands for each year during the Term of this Agreement, as determined
by reference to the Company’s audited financial statements with respect to each such year; (ii) one percent (1.0%)
of the EBITDA of the Company attributable to revenues generated from the sale of the Company’s products or services represented
by the Executive. “EBITDA” shall mean the earnings of the Company before the deduction of interest, taxes, depreciation
and amortization in accordance
with generally accepted accounting principles (GAAP) as consistently applied by the Company as determined by either (i) the firm
of independent certified public accountants engaged by the Company for purposes of its own audit or (ii) the Board of Directors
of the Company.  These amounts shall be collectively referred to herein as the “Performance Bonus”.
The Performance Bonus shall be delivered to the Executive within ten business days after delivery to the Board of Directors of
the audited financial statements by the Company’s auditors.

 

3.3Royalties.
The Executive shall receive a royalty payment (the “Royalty Fee”), in an amount to be determined by the parties, for
ten (10) years commencing upon the termination of the Executive’s employment by the Company (subject to the terms and conditions
of Sections 7.1 through 7.4 of this Agreement), in consideration for those rights set forth in Section 1.3 above during the Ten
(10) year period commencing upon the termination of the Executive’s employment by the Company. No Royalty Fee shall be owed
to the Executive in the event of such Executive’s Resignation without good cause, Termination for Cause, Death or Disability,
however, those rights of the Company provided by Section 1.3 hereof shall continue in such circumstance for Ten (10) years.

 

3.4Stock Options.
The Executive shall be granted options to purchase shares of the Company’s common stock, subject to the terms and conditions
set forth in the Stock Option Agreement between the Executive and the Company attached hereto as Exhibit B.

 

3.5Benefits. The
Executive shall be entitled to receive health care benefits to the same extent as other employees of the Company situated in the
United States, in accordance with the Company’s health insurance plans and health care policies adopted by the Board of Directors
from time-to-time, provided, however, that the Company shall not be obligated to provide such benefits to any officer, director
or employee of the Company.

 

3.6Vacation. The
Executive shall be entitled to paid vacation for each calendar year in accordance with Company policies as determined by the Board.

 

3.7Expense Reimbursement.
The Executive shall be entitled to reimbursement of reasonable out-of-pocket expenses incurred in connection with travel and matters
related to the Company's business and affairs, if made in accordance with written Company policies as in effect from time to time
as adopted by the Board.

 

    	(2)

    	 

    
 

4.Trade Secrets.

 

4.1Trade Secret
Covenants. The Executive agrees that it is in the Company's legitimate business interest to restrict disclosure or use of Trade
Secrets and Confidential Information (as defined below) relating to the Company and its affiliates as provided herein, and Executive
agrees not to disclose or use the Trade Secrets and/or Confidential Information relating to the Company or its affiliates for any
purpose other than in connection with his performance of his duties to the Company.

 

4.2“Trade
Secrets” shall mean all confidential and proprietary information belonging to the Company (including ideas, formulas,
compositions, inventions (whether patentable or unpatentable and whether or not reduced to practice), know-how, manufacturing and
production processes and techniques, research and development information, drawings, specifications, designs, plans, proposals,
technical data, copyrightable works, financial and marketing plans and customer and supplier lists and information).

 

4.3“Confidential
Information” means all information other than Trade Secrets belonging to, used by, or which is in the possession of the
Company and relating to the Company’s business or assets specifically including, but not limited to, information relating
to the Company’s products, services, strategies, pricing, customers, representatives, suppliers, distributors, technology,
finances, employee compensation, computer software and hardware, inventions, developments, in each case to the extent that such
information is not required to be disclosed by applicable law or compelled to be disclosed by any governmental authority.

 

4.4Trade Secret
Exceptions. Notwithstanding the foregoing, the terms “Trade Secrets” and “Confidential Information”
do not include information that (i) is or becomes generally available to or known by the public (other than as a result of a disclosure
by the Executive), provided, that the source of such information is not known by the Executive to be bound by a confidentiality
agreement with the Company; or (ii) is independently developed by the Executive without violating this Agreement.

 

5.Return of Documents
and Property. Upon the expiration or termination of the Executive's employment with the Company, or at any time upon the request
of the Company, the Executive (or his heirs or personal representatives) shall deliver to the Company (a) all documents and materials
(including, without limitation, computer files) containing Trade Secrets and Confidential Information relating to the business
and affairs of the Company or its affiliates, and (b) all documents, materials, equipment and other property (including, without
limitation, computer files, computer programs, computer operating systems, computers, printers, scanners, pagers, telephones, credit
cards and ID cards) belonging to the Company or its affiliates, which in either case are in the possession or under the control
of the Executive (or his heirs or personal representatives).

 

6.Discoveries and Works. All
Discoveries and Works made or conceived by the Executive during his employment by the Company, solely, jointly or with others,
that relate to the Company's present or anticipated activities, or are used or useable by the Company shall be owned by the Company.
For the purposes of this Section 6, (including the definition of “Discoveries and Works”) the term “Company”
shall include the Company and its affiliates. The term “Discoveries and Works” includes, by way of example but
without limitation, Trade Secrets and other Confidential Information, patents and patent applications, service marks, and service
mark registrations and applications, trade names, copyrights and copyright registrations and applications. The Executive shall
(a) promptly notify, make full disclosure to, and execute and deliver any documents requested by the Company, as the case may be,
to evidence or better assure title to Discoveries and Works in the Company, as so requested, (b) renounce any and all claims, including
but not limited to claims of ownership and royalty, with respect to all Discoveries and Works and all other property owned or licensed
by the Company, (c) assist the Company in obtaining or maintaining for itself at its own expense United States and foreign patents,
copyrights, trade secret protection or other protection of any and all Discoveries and Works, and (d) promptly execute, whether
during his employment with the Company or thereafter, all applications or other endorsements necessary or appropriate to maintain
patents and other rights for the Company and to protect the title of the Company thereto, including but not limited to assignments
of such patents and other rights. Any Discoveries and Works which, within one year after the expiration or termination of the Executive's
employment with the Company, are made, disclosed, reduced to tangible or written form or description, or are reduced to practice
by the Executive and which pertain to the business carried on or products or services being sold or delivered by the Company at
the time of such termination shall, as between the Executive and, the Company, be presumed to have been made during the Executive's
employment by the Company. The Executive acknowledges that all Discoveries and Works shall be deemed “works made for hire”
under the U.S. Copyright Act of 1976, as amended 17 U.S.C. Sect. 101. Should the Executive refuse or fail to perform such acts
or execute such documents, instruments or certificates, the Company may do so as the Employee’s attorney-in-fact for such
purpose.

 

    	(3)

    	 

    
 

7.Termination.

 

7.1 Termination of
Employment For Cause; Resignation. In addition to any other remedies available to the Company at law, in equity or as set forth
in this Agreement, the Company shall have the right, at its election, upon written notice to Executive, to terminate Executive’s
employment hereunder at any time for “Cause” (a “Termination For Cause”). In the event of a Termination
For Cause, or if Executive resigns other than pursuant a Termination with Good Reason pursuant to Section 7.3 below, the Company
shall have no further liability or obligation to Executive other than the Company’s obligation to pay any earned but unpaid
Base Salary and any unreimbursed expenses, in each case, through the date of termination (the “Accrued Obligations”),
in each case in accordance with Section 3 above. In the event of any Termination For Cause, the Executive shall forfeit any and
all right to any payment of Performance Fee or Royalty Fee.

 

For purposes of this
Agreement, “Cause” shall mean: (a) any act or omission that constitutes a breach by Executive of any of his
obligations under this Agreement; (b) the continued failure or refusal of Executive (i) to perform the duties required of his as
an Executive of the Company and/or (ii) to comply with directions of the CEO, (c) any violation
by Executive of any (i) policy, rule or regulation of the Company or (ii) any law or regulation applicable to the business of the
Company or any of its Affiliates; (d) any act of fraud, misappropriation, embezzlement, or similar act of dishonesty;
(e) violations of the Company’s drug use policy (including the failure to take a drug screening test as required by
the Company in accordance with such policy) or the use of alcohol or drugs (legal or illegal) in a way which impairs Executive’s
ability to perform Executive 's duties hereunder (as determined by the CEO), (f) Executive’s
gross negligence in the performance of his duties hereunder, violation of any other provisions set forth herein, or any
breach of any fiduciary duty to the Company (including the receipt by Executive of any form of payment for services performed on
behalf of, or in connection with, the business of the Company that Executive fails to promptly deliver to the Company); (g) Executive’s
conviction of, or plea of guilty or nolo contendere to, any crime (whether or not involving the Company) which constitutes a felony
or crime of moral turpitude or is punishable by imprisonment of thirty (30) days or more, provided, however, that
nothing in this Agreement shall obligate the Company to pay Base Salary or any Performance Bonus or benefits during any period
that Executive is unable to perform his duties hereunder due to any incarceration, and provided, further, that nothing
shall prevent Executive’s termination under any other subsection of this Section 7.1 if it provides independent grounds for
termination; or (h) any other misconduct by Executive that is materially injurious to the financial condition or business reputation
of, or is otherwise materially injurious to, the Company or any of its Affiliates.

 

Notwithstanding the
foregoing, no purported Termination For Cause pursuant to (a), (b), (c), (d), (e), (f) or (h) of the preceding paragraph of this
Section 7.1 shall be effective unless all of the following provisions shall have been complied with: (i) Executive shall be given
written notice by the Company of its intention to effect a Termination For Cause, such notice to state in detail the particular
circumstances that constitute the grounds on which the proposed Termination For Cause is based; and (ii) Executive shall have ten
(10) business days after receiving such notice in which to cure such grounds, to the extent such cure is possible, as determined
in the sole discretion of the Company, provided, however, that Executive shall not have such right to cure if (A) these
curable failures, violations or breaches become a pattern and (B) following written notice to Executive and consultation with
Executive to attempt to resolve the issues which the Company believes constitute such a pattern, the Company determines in good
faith that Executive is unwilling or unable to discontinue the activities constituting such a pattern.

 

Executive acknowledges
that Company’s payment of the Accrued Obligations referred to in this Section 7.1, together with any rights or benefits under
any written plan or agreement which have vested on or prior to the termination date of Executive’s employment under this
Section 7.1, constitutes the only payments which Executive shall be entitled to receive from the Company hereunder in the event
of a Termination for Cause, or if Executive resigns other than pursuant a Termination with Good Reason, and the Company shall have
no further liability or obligation to him hereunder or otherwise in respect of his employment.

 

7.2Termination of Employment Without
Cause. During the Term, the Company may at any time, at its election in its sole discretion, terminate the employment of Executive
hereunder for any reason (other than those set forth in Section 7.1 above) upon written notice (the “Termination Notice”)
to Executive (a “Termination Without Cause”).

 

In such event,
the Company shall pay Executive the following, in each case in accordance with Section 3 above, (1) the Accrued Obligations; and
(2) subject to Sections 7.5, 7.6, and 7.7 below: (a) the unpaid Performance Bonus, if any, payable with respect to the most recently
ended fiscal quarter of the applicable Contract Year and with respect to the pro rata portion of the then-current fiscal quarter
of the applicable Contract Year, determined in accordance with, Section 3, and payable, if at all, within 45 days of the end of
the applicable quarter (the “Pro Rata Performance Bonus”) and (b) the Company shall continue paying to Executive
the Base Salary as in effect on the date of termination until the earlier of (i) three weeks from the date of termination or (ii)
the end of the Term. The Executive shall thereafter be entitled to receive the Royalty Fee, but not the Base Salary or Performance
Bonus.

 

Executive acknowledges
that the payments referred to in this Section 7.2, together with any rights or benefits under any written plan or agreement which
have vested on or prior to the termination date of Executive’s employment under this Section 7.2, constitute the only payments
which Executive shall be entitled to receive from the Company hereunder in the event of any termination of his employment pursuant
to this Section 7.2, and the Company shall have no further liability or obligation to him hereunder or otherwise in respect of
his employment.

 

    	(4)

    	 

    
 

7.3 Termination of Employment With
Good Reason. Executive shall have the right during the Term, at Executive’s election and upon written notice to the Company,
to terminate his employment hereunder in the event of a material breach of a material provision of this Agreement by the Company
(a “Termination With Good Reason”). Notwithstanding the foregoing, no purported Termination With Good Reason
pursuant to this Section 7.3 shall be effective unless all of the following provisions shall have been complied with: (i) Executive
shall give the Company a written notice of Executive’s intention to effect a Termination With Good Reason, such notice to
state in detail the particular circumstances that constitute the grounds on which the proposed Termination With Good Reason is
based and to be given no later than ninety (90) days after the initial occurrence of such circumstances; (ii) the Company shall
have thirty (30) days after receiving such notice in which to cure such grounds, to the extent such cure is possible; and (iii)
if the Company fails to cure such grounds within such 30-day period, Executive actually terminates his employment hereunder on
the last day of such 30-day period.

 

In the event
that a Termination With Good Reason occurs, the Company shall pay Executive the following, in each case in accordance with Section
3 above, (1) the Accrued Obligations; and (2) subject to Sections 7.5, 7.6 and 7.7 below: (a) the Pro Rata Performance Bonus and
(b) the Company shall continue paying to Executive the Base Salary as in effect on the date of termination (x) in the event that
such termination occurs prior to the second anniversary of the Commencement Date until the second anniversary of the Commencement
Date; and (y) in the event that such termination occurs on or after the second anniversary of the Commencement Date, until the
earlier of (i) three weeks from the date of termination or (ii) the end of the Term. The Executive shall thereafter be entitled
to receive the Royalty Fee, but not the Base Salary or Performance Bonus.

 

Executive acknowledges
that the payments referred to in this Section 7.3, together with any rights or benefits under any written plan or agreement which
have vested on or prior to the termination date of Executive’s employment under this Section 7.3, constitute the only payments
which Executive shall be entitled to receive from the Company hereunder in the event of any termination of his employment pursuant
to this Section 7.3, and the Company shall have no further liability or obligation to him hereunder or otherwise in respect of
his employment.

 

7.4Death; Disability. In
the event that Executive dies or becomes Disabled (as defined herein) during the Term, Executive’s employment shall terminate
either (i) when such death occurs, or (ii) upon written notice by the Company at any time after Disability occurs (provided that,
in the event of any Disability, the Company shall have the right, but not the obligation, to terminate this Agreement. In the event
of such termination, Company shall have no further liability or obligation to Executive other than the Company’s obligation
to pay Executive the following, in each case in accordance with Section 3 above: (1) the Accrued Obligations and (2) subject to
Section 7.5, the Pro Rata Performance Bonus.

 

For the purposes of this
Agreement, Executive shall be deemed to be “Disabled” or have a “Disability” if, because
of Executive’s physical or mental disability, he has been substantially unable to perform his duties hereunder for twelve
(12) work weeks in any twelve (12) month period. Executive shall be considered to have been substantially unable to perform his
duties hereunder only if he is either (a) unable to reasonably and effectively carry out his duties with reasonable accommodations
by the Company or (b) unable to reasonably and effectively carry out his duties because any reasonable accommodation which may
be required would cause the Company undue hardship. In the event of a disagreement concerning Executive’s perceived Disability,
Executive shall submit to such examinations as are deemed appropriate by three practicing physicians specializing in the area of
Executive’s Disability, one selected by Executive, one selected by the Company, and one selected by both such physicians.
The majority decision of such three physicians shall be final and binding on the parties. Nothing in this paragraph is intended
to limit the Company’s right to invoke the provisions of this paragraph with respect to any perceived Disability of Executive.

 

Notwithstanding
the foregoing, to the extent and for the period required by any state or federal family and medical leave law, upon Executive’s
request (i) he shall be considered to be on unpaid leave of absence and not terminated, (ii) his group health benefits shall remain
in full force and effect, and (iii) if Executive recovers from any such Disability, at that time, to the extent required by any
state or federal family and medical leave law, upon Executive’s request, he shall be restored to his position hereunder or
to an equivalent position, as the Company may determine, and the Term of Executive’s employment hereunder shall be reinstated
effective upon such restoration. The Term shall not be extended by reason of such intervening leave of absence, nor shall any compensation
or benefits accrue in excess of those required by law during such intervening leave of absence. Upon the expiration of any such
rights, unless Executive has been restored to a position with the Company, he shall thereupon be considered terminated.

 

Executive acknowledges
that the payments referred to in this Section 7.4, together with any rights or benefits under any written plan or agreement which
have vested on or prior to the termination date of Executive’s employment under this Section 7.4, constitute the only payments
which Executive (or his legal representative, as the case may be) shall be entitled to receive from the Company hereunder in the
event of any termination of his employment due to Executive’s death or Disability, and the Company shall have no further
liability or obligation to him (or his legal representatives, as the case may be) hereunder or otherwise in respect of his employment.

 

    	(5)

    	 

    
 

7.5 Expiration
of Term. At the end of the Term, such term shall not be renewed and employment hereunder, if it continues at all, will be "at
will”; in other words, during any time following the expiration of the Term, (i) the Company may terminate Executive's employment
at any time, with or without reason and with or without notice, and Executive may resign at any time, with or without reason and
with or without notice and (ii) the Company has no obligation to continue Executive’s employment on the terms and conditions
set forth in this Agreement, provided that, for the avoidance of doubt, Sections 4-6 and 9-10 shall survive such expiration of
the Term in accordance with their terms. For the avoidance of doubt, Sections 7.2 and 7.3 shall not be applicable during any “at
will” employment period and Executive shall not be entitled to any severance or separation payment (including, without limitation,
the Separation Consideration) or other post-termination payments if such "at will” employment is terminated.

 

7.6Payments Following Termination;
Release. The Accrued Obligations shall be payable within 30 days following Executive’s date of termination. The Pro Rata
Performance Bonus shall be payable as set forth in Section 3. ALL PAYMENTS FOLLOWING TERMINATION (UNLESS OTHERWISE REQUIRED BY
LAW) SHALL BE SUBJECT TO THE EXECUTION, DELIVERY AND NON-REVOCATION BY EXECUTIVE OF A SEPARATION AGREEMENT AND GENERAL RELEASE
OF CLAIMS AGAINST THE COMPANY AND ITS AFFILIATES IN CUSTOMARY FORM PROVIDED BY THE COMPANY (THE “RELEASE”) WITHIN
THE APPLICABLE TIME PERIOD DESCRIBED BELOW.

 

Executive shall have a
period of twenty-one (21) days (or, if required by applicable law, a period of forty-five (45) days) after the effective date of
termination of Executive’s employment hereunder (the “Consideration Period”) in which to execute and return
the original, signed Release to the Company. If Executive does not deliver the original, signed Release to the Company prior to
the expiration of the Consideration Period, or if Executive delivers the original, signed Release to the Company prior to the expiration
of the Consideration Period and thereafter revokes such Release within any period of time provided therefor under applicable law,
then:

 

		(a)	the Company shall have no further liability or obligation to Executive other than the Company’s
obligation to pay the Accrued Obligations; and

 

		(b)	the Company shall have no obligation to pay Executive the Separation Consideration or any portion
thereof.

 

All other rights and obligations of the Company
and Executive under this Agreement shall cease as of the date of termination, except that provisions of Sections 4-6 and 9-20 of
this Agreement shall survive and continue in full force and effect.

 

7.7Continued
Compliance. Executive and the Company hereby acknowledge that any payments pursuant to Sections 7.2 or 7.3 (such payments,
the “Separation Consideration”) are part of the consideration for, and are mutually dependent upon, Executive’s
full compliance with, the provisions of this Agreement, including, without limitation, Executive’s undertakings under Sections
4-6 and 9-10. Such amounts are subject to Executive’s continued compliance with the provisions of Sections 4-6 and 9-10 of
this Agreement. If Executive violates the provisions of Sections 4-6 and 9-10, then the Company’s obligation to pay Executive
the Separation Consideration shall terminate immediately, and the Company shall have no obligation to make any of the Separation
Consideration payments that remain payable by the Company under Section 7.2 or Section 7.3, as applicable, on or after the date
of such violation.

 

8.No Conflicts.
The Executive has represented and hereby represents to the Company and its affiliates that the execution, delivery and performance
by the Executive of this Agreement do not conflict with or result in a violation or breach of, or constitute (with or without notice
or lapse of time or both) a default under any contract, agreement or understanding, whether oral or written, to which the Executive
is a party or of which the Executive is or should be aware and that there are no restrictions, covenants, agreements or limitations
on his right or ability to enter into and perform the terms of this Agreement, and agrees to indemnify and save the Company and
its affiliates harmless from any liability, cost or expense, including attorney’s fees, based upon or arising out of any
such restrictions, covenants, agreements, or limitations that may be found to exist.

 

For purposes of this Agreement,
“affiliate” shall include any person or entity directly or indirectly controlled by or controlling the Company.

 

    	(6)

    	 

    
 

9.Non-competition.

 

9.1Except as authorized
by the Board of Directors, during the Executive’s employment by the Company and for a period of one (1) year thereafter,
Executive will not (except as an officer, director, stockholder, employee, agent or consultant of the Company or any subsidiary
or affiliate thereof) either directly or indirectly, whether or not for consideration, (i) in any way, directly or indirectly,
solicit, divert, or take away the business of any person who is or was a customer of the Company, or in any manner influence such
person to cease doing business in part or in whole with Company; (ii) engage in a Competing Business; (iii) except for investments
or ownership in public entities, mutual funds and similar investments, none of which constitute more than 5% of the ownership or
control of such entities, own, operate, control, finance, manage, advise, be employed by or engaged by, perform any services for,
invest or otherwise become associated in any capacity with any person engaged in a Competing Business in the State of North Carolina;
or (iv) engage in any practice the purpose or effect of which is to intentionally evade the provisions of this covenant.

 

9.2“Competing
Business” means any company or business which is engaged directly or indirectly in the State of North Carolina in any
business carried on or planned to be carried on by the Company or any of its subsidiaries or affiliates.

 

9.3Preservation of
all Non-Competition Covenants. In the event any arbitrator or court of competent jurisdiction holds the foregoing non-competition
covenant to be non-enforceable due to lack of consideration or any other reason, the Executive acknowledges and agrees that upon
receipt of any Separation Consideration, the Executive shall remain fully bound and subject to any and all of the non-competition
covenants specified in this Agreement for the respective periods of time required thereto, as to which the Executive hereby expressly
agrees such payments will constitute fully adequate and valid consideration in all respects for all such covenants to have full
force and effect.

 

10.Non-Solicitation.
During the Executive’s employment by the Company and for a period of two years thereafter (the “Restricted Period”),
the Executive, directly or indirectly, whether for his account or for the account of any other individual or entity, shall not
solicit or canvas the trade, business or patronage of, or sell to, any individuals or entities that were either customers of the
Company during the time the Executive was employed by the Company, or prospective customers with respect to whom a sales effort,
presentation or proposal was made by the Company or its affiliates, during the two year period prior to the termination of the
Executive’s employment. The Executive further agrees that during the Restricted Period, he shall not, directly or indirectly,
(i) solicit, induce, enter into any agreement with, or attempt to influence any individual who was an employee or consultant of
the Company at any time during the time the Executive was employed by the Company, to terminate him or his employment relationship
with the Company or to become employed by the Executive or any individual or entity by which the Executive is employed; or (ii)
interfere in any other way with the employment, or other relationship, of any employee or consultant of the Company or its affiliates.

 

11.Enforcement.
The Executive agrees that any breach of the provisions of this Agreement would cause substantial and irreparable harm, not readily
ascertainable or compensable in terms of money, to the Company for which remedies at law would be inadequate and that, in addition
to any other remedy to which the Company may be entitled at law or in equity, the Company shall be entitled to temporary, preliminary
and other injunctive relief in the event the Executive violates or threatens to violate the provisions of this Agreement, as well
as damages, including, without limitation consequential damages, and an equitable accounting of all earnings, profits and benefits
arising from such violation, in each case without the need to post any security or bond. Nothing herein contained shall be construed
as prohibiting the Company from pursuing, in addition, any other remedies available to the Company for such breach or threatened
breach. A waiver by the Company of any breach of any provision hereof shall not operate or be construed as a waiver of a breach
of any other provision of this Agreement or of any subsequent breach by the Executive.

 

12.Determinations
by the Company. All determinations and calculations with respect to this Agreement shall be made in good faith by the Board
or any committee thereof to which the Board has delegated such authority, in accordance with applicable law, the certificate of
incorporation and by-laws of the Company, provided, however, such determinations and calculations shall not be binding unless or
until agreed upon by the Executive.

 

    	(7)

    	 

    
 

13.Successors and
Assigns. This Agreement shall inure to the benefit of and shall be binding upon (i) the Company, its successors and assigns,
and any company with which the Company may merge or consolidate or to which the Company may sell substantially all of its assets;
and (ii) Executive and his executors, administrators, heirs and legal representatives. Since the Executive’s services are
personal and unique in nature, the Executive may not transfer, sell or otherwise assign his rights, obligations or benefits under
this Agreement.

 

14.Notices.
Any notice required or permitted under this Agreement shall be deemed to have been effectively made or given if in writing and
personally delivered, or sent properly addressed in a sealed envelope postage prepaid by certified or registered mail, or delivered
by a reputable overnight delivery service. Unless otherwise changed by notice, notice shall be properly addressed to the Executive
if addressed to the address of record then on file with the Company; and properly addressed to the Company if addressed to:

 

Organic Plant Health, Inc.

7077 East Marilyn Road, Suite 140

Scottsdale, Arizona 85254

Telephone: 480-779-0046

Facsimile: 480-779-0177

 

With a simultaneous
copy to:

 

Wuersch & Gering
LLP

100 Wall Street,
21st Floor

New York, New York
10005

Telephone: 212-509-4723

Telecopier: 610-819-9104

Attention: Travis
L. Gering, Esq.

travis.gering@wg-law.com

 

15.Severability.
It is expressly understood and agreed that although the Company and the Executive consider the restrictions contained in this Agreement
to be reasonable and necessary for the purpose of preserving the goodwill, proprietary rights and going concern value of the Company,
if a final determination is made by arbitration or any court having jurisdiction that any provision contained in this Agreement
is invalid, the provisions of this Agreement shall not be rendered void but shall be deemed amended to apply as to such maximum
time and territory and to such other extent as such arbitral body or court may determine or indicate to be reasonable. Alternatively,
if the arbitrable body or court finds that any provision or restriction contained in this Agreement or any remedy provided herein
is unenforceable, and such restriction or remedy cannot be amended so as to make it enforceable, such finding shall not affect
the enforceability of any of the other restrictions contained therein or the availability of any other remedy. The provisions of
this Agreement shall in no respect limit or otherwise affect the Executive's obligations under any other agreements with the Company.

 

16.Construction.
This Agreement has been jointly negotiated and drafted by the parties and in the event of any ambiguity no provision herein shall
be construed against any party as the draftsperson. Each reference to “business day” shall mean any day on which the
New York Stock Exchange is open for business.

 

17.Effects of Termination.
Notwithstanding anything to the contrary contained herein, if this Agreement is terminated pursuant to Section 7 or expires by
its terms, the provisions of Sections 4-6 and 9-20 of this Agreement shall survive and continue in full force and effect, provided,
however, any and all rights of the Executive with respect to the terms of compensation and enforcement thereof shall survive and
remain fully enforceable.

 

18.Miscellaneous.
This Agreement constitutes the entire agreement, and supersedes all prior agreements, of the parties hereto relating to the subject
matter hereof, and there are no written or oral terms or representations made by either party other than those contained herein.
This Agreement cannot be modified, altered or amended except by a writing signed by both parties. No waiver by either party of
any provision or condition of this Agreement at any time shall be deemed a waiver of such provision or condition at any prior or
subsequent time or of any other provision or condition at the same or any prior or subsequent time.

 

19.Governing Law;
Arbitration. This Agreement shall be governed by and construed in accordance with the domestic Laws of the State of Arizona,
without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Arizona or any other jurisdiction)
that would cause the application of the Laws of any jurisdiction other than the State of Arizona. All disputes and controversies
arising out of or relating to this Agreement shall be finally settled and binding under the Commercial Arbitration Rules of the
American Arbitration Association (“AAA”). The place of arbitration shall be Scottsdale, Arizona. Any award,
verdict or settlement issued under such arbitration may be entered by any Party for order of enforcement by any court of competent
jurisdiction. The arbitrator shall power to take interim measures he or he deems necessary, including injunctive relief and measures
for the protection or conservation of property and disposition of perishable goods.

 

20.Counterparts.
This Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all of which together
will constitute one and the same instrument.

 

    	(9)

    	 

    
 

 

IN WITNESS WHEREOF, the parties have executed
this Agreement as of the day and year first above written.

 

 /s/ Billy Styles 

EXECUTIVE: William Styles

 

 

 

 

THE COMPANY: Organic Plant Health,
Inc.

 

 

   By: /s/ J.
Alan Talbert

Name:J. Alan Talbert

Title:VP Operations

 

    	(10)

    	 

    

 

 

Exhibit A

 

Release

 

Exhibit B

 

Stock Option AgreementEXECUTIVE
EMPLOYMENT AGREEMENT

 

EMPLOYMENT
AGREEMENT, dated this  24th day of January 2013 (the “Agreement”), by and among Organic Plant
Health, Inc., a Nevada corporation (the “Company”), and J. Alan Talbert (the
“Executive”).

 

WHEREAS,
the Company desires to memorialize the engagement of the Executive who has been previously appointed to serve as the Vice President
of Operations of the Organic Plant Health division of the Company and the Executive desires to continue to serve in
such capacity pursuant to the terms and conditions hereof;

 

NOW
THEREFORE, in consideration of the premises and the mutual agreements made herein, the Company and the Executive agree as follows:

 

1.Employment;
Duties. The Company hereby engages the Executive to serve as Vice President of Operations of the Organic Plant Health
division of the Company subject to the terms and conditions of this Agreement. The Executive shall serve the Company in
such capacity for the Employment Period as defined in Section 2 below. The Executive agrees that during the term of his employment
hereunder, he shall exclusively devote 100% of his professional working time, attention, knowledge and experience and give his
best effort, skill and abilities to promote the business and interests of the Company as reasonably directed by the Chief Executive
Officer (the “CEO”) pursuant to policies of the Board of Directors of the Company (the “Board”).
The Executive agrees to faithfully and diligently perform such duties as may from time to time be reasonably assigned by the CEO
under the terms and conditions of this Agreement.

 

2.Employment
Period. This Agreement shall have a term of three (3) years (the “Employment Period”)
to be effective as of the date hereof and ending on the third anniversary of the date of this Agreement. The period in which this
Agreement shall be effective within each Employment Period is referred to as a “Term”.

 

3.Compensation
and Benefits.

 

3.1Base
Compensation and Annual Bonus. The Executive shall be paid a base salary of Eighty Thousand Dollars ($80,000) per annum
during the Term, payable incrementally on a monthly basis and pro-rated for any partial year of employment, less applicable statutory
and regulatory deductions (each year, the “Base Salary”), which shall be payable in accordance with the Company’s
regular monthly payroll practices, as the same may be administered from time to time.

 

3.2
Cash Bonuses. The Executive shall be entitled to receive a performance bonus of cash, less applicable statutory and
regulatory deductions, in an amount equal to one percent (1.0%) of the EBITDA of the Company attributable to revenues generated
from sale of the Organic Plant Health division’s products or services or licensing revenues derived from licensing the Organic
Plant Health division’s intellectual property and/or brands for each year during the Term of this Agreement, as determined
by reference to the Company’s audited financial statements with respect to each such year. “EBITDA” shall
mean the earnings of the Company before the deduction of interest, taxes, depreciation
and amortization in accordance with generally
accepted accounting principles (GAAP) as consistently applied by the Company as determined by either (i) the firm of independent
certified public accountants engaged by the Company for purposes of its own audit or (ii) the Board of Directors of the Company. 
This amount shall be referred to herein as the “Performance Bonus”. The Performance Bonus shall be delivered
to the Executive within ten business days after delivery to the Board of Directors of the audited financial statements by the
Company’s auditors.

 

3.3Stock
Options. The Executive shall be granted options to purchase shares of the Company’s common stock, subject to the terms
and conditions set forth in the Stock Option Agreement between the Executive and the Company attached hereto as Exhibit
A.

 

3.4Benefits.
The Executive shall be entitled to receive health care benefits to the same extent as other employees of the Company situated
in the United States, in accordance with the Company’s health insurance plans and health care policies adopted by the Board
of Directors from time-to-time, provided, however, that the Company shall not be obligated to provide such benefits to any officer,
director or employee of the Company.

 

    	(1)

    	 

    
 

3.5Vacation.
The Executive shall be entitled to paid vacation for each calendar year in accordance with Company policies as determined by the
Board.

 

3.6Expense
Reimbursement. The Executive shall be entitled to reimbursement of reasonable out-of-pocket expenses incurred in connection
with travel and matters related to the Company's business and affairs, if made in accordance with written Company policies as
in effect from time to time as adopted by the Board.

 

4.Trade
Secrets.

 

4.1Trade
Secret Covenants. The Executive agrees that it is in the Company's legitimate business interest to restrict disclosure or
use of Trade Secrets and Confidential Information (as defined below) relating to the Company and its affiliates as provided herein,
and Executive agrees not to disclose or use the Trade Secrets and/or Confidential Information relating to the Company or its affiliates
for any purpose other than in connection with his performance of his duties to the Company.

 

4.2“Trade
Secrets” shall mean all confidential and proprietary information belonging to the Company (including ideas, formulas,
compositions, inventions (whether patentable or unpatentable and whether or not reduced to practice), know-how, manufacturing
and production processes and techniques, research and development information, drawings, specifications, designs, plans, proposals,
technical data, copyrightable works, financial and marketing plans and customer and supplier lists and information).

  

4.3“Confidential
Information” means all information other than Trade Secrets belonging to, used by, or which is in the possession of
the Company and relating to the Company’s business or assets specifically including, but not limited to, information relating
to the Company’s products, services, strategies, pricing, customers, representatives, suppliers, distributors, technology,
finances, employee compensation, computer software and hardware, inventions, developments, in each case to the extent that such
information is not required to be disclosed by applicable law or compelled to be disclosed by any governmental authority.

4.4Trade
Secret Exceptions. Notwithstanding the foregoing, the terms “Trade Secrets” and “Confidential
Information” do not include information that (i) is or becomes generally available to or known by the public (other
than as a result of a disclosure by the Executive), provided, that the source of such information is not known by
the Executive to be bound by a confidentiality agreement with the Company; or (ii) is independently developed by the Executive
without violating this Agreement.

 

5.Return
of Documents and Property. Upon the expiration or termination of the Executive's employment with the Company, or at any time
upon the request of the Company, the Executive (or his heirs or personal representatives) shall deliver to the Company (a) all
documents and materials (including, without limitation, computer files) containing Trade Secrets and Confidential Information
relating to the business and affairs of the Company or its affiliates, and (b) all documents, materials, equipment and other property
(including, without limitation, computer files, computer programs, computer operating systems, computers, printers, scanners,
pagers, telephones, credit cards and ID cards) belonging to the Company or its affiliates, which in either case are in the possession
or under the control of the Executive (or his heirs or personal representatives).

 

6.Discoveries
and Works. All Discoveries and Works made or conceived by the Executive during his employment by the Company, solely, jointly
or with others, that relate to the Company's present or anticipated activities, or are used or useable by the Company shall be
owned by the Company. For the purposes of this Section 6, (including the definition of “Discoveries and Works”)
the term “Company” shall include the Company and its affiliates. The term “Discoveries and Works”
includes, by way of example but without limitation, Trade Secrets and other Confidential Information, patents and patent applications,
service marks, and service mark registrations and applications, trade names, copyrights and copyright registrations and applications.
The Executive shall (a) promptly notify, make full disclosure to, and execute and deliver any documents requested by the Company,
as the case may be, to evidence or better assure title to Discoveries and Works in the Company, as so requested, (b) renounce
any and all claims, including but not limited to claims of ownership and royalty, with respect to all Discoveries and Works and
all other property owned or licensed by the Company, (c) assist the Company in obtaining or maintaining for itself at its own
expense United States and foreign patents, copyrights, trade secret protection or other protection of any and all Discoveries
and Works, and (d) promptly execute, whether during his employment with the Company or thereafter, all applications or other endorsements
necessary or appropriate to maintain patents and other rights for the Company and to protect the title of the Company thereto,
including but not limited to assignments of such patents and other rights. Any Discoveries and Works which, within one year after
the expiration or termination of the Executive's employment with the Company, are made, disclosed, reduced to tangible or written
form or description, or are reduced to practice by the Executive and which pertain to the business carried on or products or services
being sold or delivered by the Company at the time of such termination shall, as between the Executive and, the Company, be presumed
to have been made during the Executive's employment by the Company. The Executive acknowledges that all Discoveries and Works
shall be deemed “works made for hire” under the U.S. Copyright Act of 1976, as amended 17 U.S.C. Sect. 101.
Should the Executive refuse or fail to perform such acts or execute such documents, instruments or certificates, the Company may
do so as the Employee’s attorney-in-fact for such purpose.

 

    	(2)

    	 

    
 

7.Termination.

 

7.1
Termination of Employment For Cause; Resignation. In addition to any other remedies available to the Company at law, in
equity or as set forth in this Agreement, the Company shall have the right, at its election, upon written notice to Executive,
to terminate Executive’s employment hereunder at any time for “Cause” (a “Termination For Cause”).
In the event of a Termination For Cause, or if Executive resigns other than pursuant a Termination with Good Reason pursuant to
Section 7.3 below, the Company shall have no further liability or obligation to Executive other than the Company’s obligation
to pay any earned but unpaid Base Salary and any unreimbursed expenses, in each case, through the date of termination (the “Accrued
Obligations”), in each case in accordance with Section 3 above. In the event of any Termination For Cause, the Executive
shall forfeit any and all right to any payment of the Performance Fee.

 

For
purposes of this Agreement, “Cause” shall mean: (a) any act or omission that constitutes a breach by Executive
of any of his obligations under this Agreement; (b) the continued failure or refusal of Executive (i) to perform the duties required
of his as an Executive of the Company and/or (ii) to comply with directions of the CEO, (c) any
violation by Executive of any (i) policy, rule or regulation of the Company or (ii) any law or regulation applicable to the business
of the Company or any of its Affiliates; (d) any act of fraud, misappropriation, embezzlement, or similar act of dishonesty;
(e) violations of the Company’s drug use policy (including the failure to take a drug screening test as required
by the Company in accordance with such policy) or the use of alcohol or drugs (legal or illegal) in a way which impairs Executive’s
ability to perform Executive 's duties hereunder (as determined by the CEO), (f) Executive’s
gross negligence in the performance of his duties hereunder, violation of any other provisions set forth herein, or any
breach of any fiduciary duty to the Company (including the receipt by Executive of any form of payment for services performed
on behalf of, or in connection with, the business of the Company that Executive fails to promptly deliver to the Company); (g)
Executive’s conviction of, or plea of guilty or nolo contendere to, any crime (whether
or not involving the Company) which constitutes a felony or crime of moral turpitude or is punishable by imprisonment of thirty
(30) days or more, provided, however, that nothing in this Agreement shall obligate the Company to pay Base Salary
or any Performance Bonus or benefits during any period that Executive is unable to perform his duties hereunder due to any incarceration,
and provided, further, that nothing shall prevent Executive’s termination under any other subsection of this
Section 7.1 if it provides independent grounds for termination; or (h) any other misconduct by Executive that is materially injurious
to the financial condition or business reputation of, or is otherwise materially injurious to, the Company or any of its Affiliates.

 

Notwithstanding
the foregoing, no purported Termination For Cause pursuant to (a), (b), (c), (d), (e), (f) or (h) of the preceding paragraph of
this Section 7.1 shall be effective unless all of the following provisions shall have been complied with: (i) Executive shall
be given written notice by the Company of its intention to effect a Termination For Cause, such notice to state in detail the
particular circumstances that constitute the grounds on which the proposed Termination For Cause is based; and (ii) Executive
shall have ten (10) business days after receiving such notice in which to cure such grounds, to the extent such cure is possible,
as determined in the sole discretion of the Company, provided, however, that Executive shall not have such right
to cure if (A) these curable failures, violations or breaches become a pattern and (B) following written notice to Executive
and consultation with Executive to attempt to resolve the issues which the Company believes constitute such a pattern, the Company
determines in good faith that Executive is unwilling or unable to discontinue the activities constituting such a pattern.

 

Executive
acknowledges that Company’s payment of the Accrued Obligations referred to in this Section 7.1, together with any rights
or benefits under any written plan or agreement which have vested on or prior to the termination date of Executive’s employment
under this Section 7.1, constitutes the only payments which Executive shall be entitled to receive from the Company hereunder
in the event of a Termination for Cause, or if Executive resigns other than pursuant a Termination with Good Reason, and the Company
shall have no further liability or obligation to him hereunder or otherwise in respect of his employment.

 

    	(3)

    	 

    
 

7.2Termination
of Employment Without Cause. During the Term, the Company may at any time, at its election in its sole discretion, terminate
the employment of Executive hereunder for any reason (other than those set forth in Section 7.1 above) upon written notice (the
“Termination Notice”) to Executive (a “Termination Without Cause”).

 

In
such event, the Company shall pay Executive the following, in each case in accordance with Section 3 above, (1) the Accrued Obligations;
and (2) subject to Sections 7.5, 7.6, and 7.7 below: (a) the unpaid Performance Bonus, if any, payable with respect to the most
recently ended fiscal quarter of the applicable Contract Year and with respect to the pro rata portion of the then-current fiscal
quarter of the applicable Contract Year, determined in accordance with, Section 3, and payable, if at all, within 45 days of the
end of the applicable quarter (the “Pro Rata Performance Bonus”) and (b) the Company shall continue paying
to Executive the Base Salary as in effect on the date of termination until the earlier of (i) three weeks from the date of termination
or (ii) the end of the Term. The Executive shall thereafter not be entitled to receive the Base Salary or Performance Bonus.

 

Executive
acknowledges that the payments referred to in this Section 7.2, together with any rights or benefits under any written plan or
agreement which have vested on or prior to the termination date of Executive’s employment under this Section 7.2, constitute
the only payments which Executive shall be entitled to receive from the Company hereunder in the event of any termination of his
employment pursuant to this Section 7.2, and the Company shall have no further liability or obligation to him hereunder or otherwise
in respect of his employment.

 

7.3
Termination of Employment With Good Reason. Executive shall have the right during the Term, at Executive’s election
and upon written notice to the Company, to terminate his employment hereunder in the event of a material breach of a material
provision of this Agreement by the Company (a “Termination With Good Reason”). Notwithstanding the foregoing,
no purported Termination With Good Reason pursuant to this Section 7.3 shall be effective unless all of the following provisions
shall have been complied with: (i) Executive shall give the Company a written notice of Executive’s intention to effect
a Termination With Good Reason, such notice to state in detail the particular circumstances that constitute the grounds on which
the proposed Termination With Good Reason is based and to be given no later than ninety (90) days after the initial occurrence
of such circumstances; (ii) the Company shall have thirty (30) days after receiving such notice in which to cure such grounds,
to the extent such cure is possible; and (iii) if the Company fails to cure such grounds within such 30-day period, Executive
actually terminates his employment hereunder on the last day of such 30-day period.

 

In
the event that a Termination With Good Reason occurs, the Company shall pay Executive the following, in each case in accordance
with Section 3 above, (1) the Accrued Obligations; and (2) subject to Sections 7.5, 7.6 and 7.7 below: (a) the Pro Rata Performance
Bonus and (b) the Company shall continue paying to Executive the Base Salary as in effect on the date of termination (x) in the
event that such termination occurs prior to the second anniversary of the Commencement Date until the second anniversary of the
Commencement Date; and (y) in the event that such termination occurs on or after the second anniversary of the Commencement Date,
until the earlier of (i) three weeks from the date of termination or (ii) the end of the Term. The Executive shall thereafter
not be entitled to receive the Base Salary or Performance Bonus.

 

Executive
acknowledges that the payments referred to in this Section 7.3, together with any rights or benefits under any written plan or
agreement which have vested on or prior to the termination date of Executive’s employment under this Section 7.3, constitute
the only payments which Executive shall be entitled to receive from the Company hereunder in the event of any termination of his
employment pursuant to this Section 7.3, and the Company shall have no further liability or obligation to him hereunder or otherwise
in respect of his employment.

 

7.4Death;
Disability. In the event that Executive dies or becomes Disabled (as defined herein) during the Term, Executive’s employment
shall terminate either (i) when such death occurs, or (ii) upon written notice by the Company at any time after Disability occurs
(provided that, in the event of any Disability, the Company shall have the right, but not the obligation, to terminate this Agreement.
In the event of such termination, Company shall have no further liability or obligation to Executive other than the Company’s
obligation to pay Executive the following, in each case in accordance with Section 3 above: (1) the Accrued Obligations and (2)
subject to Section 7.5, the Pro Rata Performance Bonus.

 

    	(4)

    	 

    
 

For
the purposes of this Agreement, Executive shall be deemed to be “Disabled” or have a “Disability”
if, because of Executive’s physical or mental disability, he has been substantially unable to perform his duties hereunder
for twelve (12) work weeks in any twelve (12) month period. Executive shall be considered to have been substantially unable to
perform his duties hereunder only if he is either (a) unable to reasonably and effectively carry out his duties with reasonable
accommodations by the Company or (b) unable to reasonably and effectively carry out his duties because any reasonable accommodation
which may be required would cause the Company undue hardship. In the event of a disagreement concerning Executive’s perceived
Disability, Executive shall submit to such examinations as are deemed appropriate by three practicing physicians specializing
in the area of Executive’s Disability, one selected by Executive, one selected by the Company, and one selected by both
such physicians. The majority decision of such three physicians shall be final and binding on the parties. Nothing in this paragraph
is intended to limit the Company’s right to invoke the provisions of this paragraph with respect to any perceived Disability
of Executive.

 

Notwithstanding
the foregoing, to the extent and for the period required by any state or federal family and medical leave law, upon Executive’s
request (i) he shall be considered to be on unpaid leave of absence and not terminated, (ii) his group health benefits shall remain
in full force and effect, and (iii) if Executive recovers from any such Disability, at that time, to the extent required by any
state or federal family and medical leave law, upon Executive’s request, he shall be restored to his position hereunder
or to an equivalent position, as the Company may determine, and the Term of Executive’s employment hereunder shall be reinstated
effective upon such restoration. The Term shall not be extended by reason of such intervening leave of absence, nor shall any
compensation or benefits accrue in excess of those required by law during such intervening leave of absence. Upon the expiration
of any such rights, unless Executive has been restored to a position with the Company, he shall thereupon be considered terminated.

 

Executive
acknowledges that the payments referred to in this Section 7.4, together with any rights or benefits under any written plan or
agreement which have vested on or prior to the termination date of Executive’s employment under this Section 7.4, constitute
the only payments which Executive (or his legal representative, as the case may be) shall be entitled to receive from the Company
hereunder in the event of any termination of his employment due to Executive’s death or Disability, and the Company shall
have no further liability or obligation to him (or his legal representatives, as the case may be) hereunder or otherwise in respect
of his employment.

 

7.5
Expiration of Term. At the end of the Term, such term shall not be renewed and employment hereunder, if it continues
at all, will be "at will”; in other words, during any time following the expiration of the Term, (i) the Company may
terminate Executive's employment at any time, with or without reason and with or without notice, and Executive may resign at any
time, with or without reason and with or without notice and (ii) the Company has no obligation to continue Executive’s employment
on the terms and conditions set forth in this Agreement, provided that, for the avoidance of doubt, Sections 4-6 and 9-10 shall
survive such expiration of the Term in accordance with their terms. For the avoidance of doubt, Sections 7.2 and 7.3 shall not
be applicable during any “at will” employment period and Executive shall not be entitled to any severance or separation
payment (including, without limitation, the Separation Consideration) or other post-termination payments if such "at will”
employment is terminated.

 

7.6Payments
Following Termination; Release. The Accrued Obligations shall be payable within 30 days following Executive’s date of
termination. The Pro Rata Performance Bonus shall be payable as set forth in Section 3. ALL PAYMENTS FOLLOWING TERMINATION (UNLESS
OTHERWISE REQUIRED BY LAW) SHALL BE SUBJECT TO THE EXECUTION, DELIVERY AND NON-REVOCATION BY EXECUTIVE OF A SEPARATION AGREEMENT
AND GENERAL RELEASE OF CLAIMS AGAINST THE COMPANY AND ITS AFFILIATES IN CUSTOMARY FORM PROVIDED BY THE COMPANY (THE “RELEASE”)
WITHIN THE APPLICABLE TIME PERIOD DESCRIBED BELOW.

 

    	(5)

    	 

    
 

Executive
shall have a period of twenty-one (21) days (or, if required by applicable law, a period of forty-five (45) days) after the effective
date of termination of Executive’s employment hereunder (the “Consideration Period”) in which to execute
and return the original, signed Release to the Company. If Executive does not deliver the original, signed Release to the Company
prior to the expiration of the Consideration Period, or if Executive delivers the original, signed Release to the Company prior
to the expiration of the Consideration Period and thereafter revokes such Release within any period of time provided therefor
under applicable law, then:

 

		(a)	the
                                                                                                                                 Company
                                                                                                                                 shall
                                                                                                                                 have
                                                                                                                                 no
                                                                                                                                 further
                                                                                                                                 liability
                                                                                                                                 or
                                                                                                                                 obligation
                                                                                                                                 to
                                                                                                                                 Executive
                                                                                                                                 other
                                                                                                                                 than
                                                                                                                                 the
                                                                                                                                 Company’s
                                                                                                                                 obligation
                                                                                                                                 to
                                                                                                                                 pay
                                                                                                                                 the
                                                                                                                                 Accrued
                                                                                                                                 Obligations;
                                                                                                                                 and

 

		(b)	the
                                                                                                                                 Company
                                                                                                                                 shall
                                                                                                                                 have
                                                                                                                                 no
                                                                                                                                 obligation
                                                                                                                                 to
                                                                                                                                 pay
                                                                                                                                 Executive
                                                                                                                                 the
                                                                                                                                 Separation
                                                                                                                                 Consideration
                                                                                                                                 or
                                                                                                                                 any
                                                                                                                                 portion
                                                                                                                                 thereof.

 

All
other rights and obligations of the Company and Executive under this Agreement shall cease as of the date of termination, except
that provisions of Sections 4-6 and 9-20 of this Agreement shall survive and continue in full force and effect.

 

7.7Continued
Compliance. Executive and the Company hereby acknowledge that any payments pursuant to Sections 7.2 or 7.3 (such payments,
the “Separation Consideration”) are part of the consideration for, and are mutually dependent upon, Executive’s
full compliance with, the provisions of this Agreement, including, without limitation, Executive’s undertakings under Sections
4-6 and 9-10. Such amounts are subject to Executive’s continued compliance with the provisions of Sections 4-6 and 9-10
of this Agreement. If Executive violates the provisions of Sections 4-6 and 9-10, then the Company’s obligation to pay Executive
the Separation Consideration shall terminate immediately, and the Company shall have no obligation to make any of the Separation
Consideration payments that remain payable by the Company under Section 7.2 or Section 7.3, as applicable, on or after the date
of such violation.

 

8.No
Conflicts. The Executive has represented and hereby represents to the Company and its affiliates that the execution, delivery
and performance by the Executive of this Agreement do not conflict with or result in a violation or breach of, or constitute (with
or without notice or lapse of time or both) a default under any contract, agreement or understanding, whether oral or written,
to which the Executive is a party or of which the Executive is or should be aware and that there are no restrictions, covenants,
agreements or limitations on his right or ability to enter into and perform the terms of this Agreement, and agrees to indemnify
and save the Company and its affiliates harmless from any liability, cost or expense, including attorney’s fees, based upon
or arising out of any such restrictions, covenants, agreements, or limitations that may be found to exist.

 

For
purposes of this Agreement, “affiliate” shall include any person or entity directly or indirectly controlled
by or controlling the Company.

 

    	(6)

    	 

    
 

9.Non-competition.

 

9.1Except
as authorized by the Board of Directors, during the Executive’s employment by the Company and for a period of one (1) year
thereafter, Executive will not (except as an officer, director, stockholder, employee, agent or consultant of the Company or any
subsidiary or affiliate thereof) either directly or indirectly, whether or not for consideration, (i) in any way, directly or
indirectly, solicit, divert, or take away the business of any person who is or was a customer of the Company, or in any manner
influence such person to cease doing business in part or in whole with Company; (ii) engage in a Competing Business; (iii) except
for investments or ownership in public entities, mutual funds and similar investments, none of which constitute more than 5% of
the ownership or control of such entities, own, operate, control, finance, manage, advise, be employed by or engaged by, perform
any services for, invest or otherwise become associated in any capacity with any person engaged in a Competing Business in the
State of North Carolina; or (iv) engage in any practice the purpose or effect of which is to intentionally evade the provisions
of this covenant.

 

9.2“Competing
Business” means any company or business which is engaged directly or indirectly in the State of North Carolina in any
business carried on or planned to be carried on by the Company or any of its subsidiaries or affiliates.

 

9.3Preservation
of all Non-Competition Covenants. In the event any arbitrator or court of competent jurisdiction holds the foregoing non-competition
covenant to be non-enforceable due to lack of consideration or any other reason, the Executive acknowledges and agrees that upon
receipt of any Separation Consideration, the Executive shall remain fully bound and subject to any and all of the non-competition
covenants specified in this Agreement for the respective periods of time required thereto, as to which the Executive hereby expressly
agrees such payments will constitute fully adequate and valid consideration in all respects for all such covenants to have full
force and effect.

 

10.Non-Solicitation.
During the Executive’s employment by the Company and for a period of two years thereafter (the “Restricted Period”),
the Executive, directly or indirectly, whether for his account or for the account of any other individual or entity, shall not
solicit or canvas the trade, business or patronage of, or sell to, any individuals or entities that were either customers of the
Company during the time the Executive was employed by the Company, or prospective customers with respect to whom a sales effort,
presentation or proposal was made by the Company or its affiliates, during the two year period prior to the termination of the
Executive’s employment. The Executive further agrees that during the Restricted Period, he shall not, directly or indirectly,
(i) solicit, induce, enter into any agreement with, or attempt to influence any individual who was an employee or consultant of
the Company at any time during the time the Executive was employed by the Company, to terminate him or his employment relationship
with the Company or to become employed by the Executive or any individual or entity by which the Executive is employed; or (ii)
interfere in any other way with the employment, or other relationship, of any employee or consultant of the Company or its affiliates.

 

11.Enforcement.
The Executive agrees that any breach of the provisions of this Agreement would cause substantial and irreparable harm, not readily
ascertainable or compensable in terms of money, to the Company for which remedies at law would be inadequate and that, in addition
to any other remedy to which the Company may be entitled at law or in equity, the Company shall be entitled to temporary, preliminary
and other injunctive relief in the event the Executive violates or threatens to violate the provisions of this Agreement, as well
as damages, including, without limitation consequential damages, and an equitable accounting of all earnings, profits and benefits
arising from such violation, in each case without the need to post any security or bond. Nothing herein contained shall be construed
as prohibiting the Company from pursuing, in addition, any other remedies available to the Company for such breach or threatened
breach. A waiver by the Company of any breach of any provision hereof shall not operate or be construed as a waiver of a breach
of any other provision of this Agreement or of any subsequent breach by the Executive.

 

    	(7)

    	 

    
 

12.Determinations
by the Company. All determinations and calculations with respect to this Agreement shall be made in good faith by the Board
or any committee thereof to which the Board has delegated such authority, in accordance with applicable law, the certificate of
incorporation and by-laws of the Company, provided, however, such determinations and calculations shall not be binding unless
or until agreed upon by the Executive.

 

13.Successors
and Assigns. This Agreement shall inure to the benefit of and shall be binding upon (i) the Company, its successors and assigns,
and any company with which the Company may merge or consolidate or to which the Company may sell substantially all of its assets;
and (ii) Executive and his executors, administrators, heirs and legal representatives. Since the Executive’s services are
personal and unique in nature, the Executive may not transfer, sell or otherwise assign his rights, obligations or benefits under
this Agreement.

 

14.Notices.
Any notice required or permitted under this Agreement shall be deemed to have been effectively made or given if in writing and
personally delivered, or sent properly addressed in a sealed envelope postage prepaid by certified or registered mail, or delivered
by a reputable overnight delivery service. Unless otherwise changed by notice, notice shall be properly addressed to the Executive
if addressed to the address of record then on file with the Company; and properly addressed to the Company if addressed to:

 

Organic
Plant Health, Inc.

7077
East Marilyn Road, Suite 140

Scottsdale,
Arizona 85254

Telephone:
480-779-0046

Facsimile:
480-779-0177

 

With
a simultaneous copy to:

 

Wuersch
& Gering LLP

100
Wall Street, 21st Floor

New
York, New York 10005

Telephone:
212-509-4723

Telecopier:
610-819-9104

Attention:
Travis L. Gering, Esq.

travis.gering@wg-law.com

 

15.Severability.
It is expressly understood and agreed that although the Company and the Executive consider the restrictions contained in this
Agreement to be reasonable and necessary for the purpose of preserving the goodwill, proprietary rights and going concern value
of the Company, if a final determination is made by arbitration or any court having jurisdiction that any provision contained
in this Agreement is invalid, the provisions of this Agreement shall not be rendered void but shall be deemed amended to apply
as to such maximum time and territory and to such other extent as such arbitral body or court may determine or indicate to be
reasonable. Alternatively, if the arbitrable body or court finds that any provision or restriction contained in this Agreement
or any remedy provided herein is unenforceable, and such restriction or remedy cannot be amended so as to make it enforceable,
such finding shall not affect the enforceability of any of the other restrictions contained therein or the availability of any
other remedy. The provisions of this Agreement shall in no respect limit or otherwise affect the Executive's obligations under
any other agreements with the Company.

 

16.Construction.
This Agreement has been jointly negotiated and drafted by the parties and in the event of any ambiguity no provision herein shall
be construed against any party as the draftsperson. Each reference to “business day” shall mean any day on which the
New York Stock Exchange is open for business.

 

17.Effects
of Termination. Notwithstanding anything to the contrary contained herein, if this Agreement is terminated pursuant to Section
7 or expires by its terms, the provisions of Sections 4-6 and 9-20 of this Agreement shall survive and continue in full force
and effect, provided, however, any and all rights of the Executive with respect to the terms of compensation and enforcement thereof
shall survive and remain fully enforceable.

 

    	(8)

    	 

    
 

18.Miscellaneous.
This Agreement constitutes the entire agreement, and supersedes all prior agreements, of the parties hereto relating to the subject
matter hereof, and there are no written or oral terms or representations made by either party other than those contained herein.
This Agreement cannot be modified, altered or amended except by a writing signed by both parties. No waiver by either party of
any provision or condition of this Agreement at any time shall be deemed a waiver of such provision or condition at any prior
or subsequent time or of any other provision or condition at the same or any prior or subsequent time.

 

19.Governing
Law; Arbitration. This Agreement shall be governed by and construed in accordance with the domestic Laws of the State of Arizona,
without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Arizona or any other
jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Arizona. All disputes and
controversies arising out of or relating to this Agreement shall be finally settled and binding under the Commercial Arbitration
Rules of the American Arbitration Association (“AAA”). The place of arbitration shall be Scottsdale, Arizona.
Any award, verdict or settlement issued under such arbitration may be entered by any Party for order of enforcement by any court
of competent jurisdiction. The arbitrator shall power to take interim measures he or he deems necessary, including injunctive
relief and measures for the protection or conservation of property and disposition of perishable goods.

 

20.Counterparts.
This Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all of which together
will constitute one and the same instrument.

 

###

 

    	(9)

    	 

    

 

IN
WITNESS WHEREOF, the parties have executed this Agreement as of the day and year first above written.

 

/s/
J. Alan Talbert

EXECUTIVE:
J. Alan Talbert

 

 

 

 

THE
COMPANY: Organic Plant Health, Inc.

 

  

 By:
/s/ Billy Styles

Name:Billy Styles

Title:
President 

 

    	(10)

    	 

    

 

 

Exhibit
A

 

Stock
Option Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00212-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00212-of-00352.parquet"}]]